Search Result "HuR inhibition"
HuR as Therapeutic Target in Cancer: What the Future Holds
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 1 Year: 2022 Page: 56-65
Author(s): Dimitrios Goutas,Alexandros Pergaris,Constantinos Giaginis,Stamatios Theocharis
Targeting the Multifaceted HuR Protein, Benefits and Caveats
Journal: Current Drug Targets
Volume: 16 Issue: 5 Year: 2015 Page: 499-515
Author(s): Chiara Zucal,Vito D’Agostino,Rosa Loffredo,Barbara Mantelli,NatthakanThongon,Preet Lal,Elisa Latorre,Alessandro Provenzani
Regulation of the mRNA-Binding Protein HuR by Posttranslational Modification: Spotlight on Phosphorylation
Journal: Current Protein & Peptide Science
Volume: 13 Issue: 4 Year: 2012 Page: 380-390
Author(s): Wolfgang Eberhardt,Anke Doller,Josef Pfeilschifter
Functional Interplay between RNA-Binding Protein HuR and microRNAs
Journal: Current Protein & Peptide Science
Volume: 13 Issue: 4 Year: 2012 Page: 372-379
Author(s): Subramanya Srikantan,Kumiko Tominaga,Myriam Gorospe
The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 5 Year: 2019 Page: 382-399
Author(s): Mingxia Wu,Christy W.S. Tong,Wei Yan,Kenneth K.W. To,William C.S. Cho
Post-Transcriptional Regulation of HSP70 Expression Following Oxidative Stress in SH-SY5Y Cells: The Potential Involvement of the RNA-Binding Protein HuR
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2651-2658
Author(s): M. Amadio, G. Scapagnini, U. Laforenza, M. Intrieri, L. Romeo, S. Govoni, A. Pascale
Acetylcholinesterase: Mechanism of Catalysis and Inhibition
Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1 Issue: 2 Year: 2001 Page: 155-170
Author(s): V. Tougu
Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2018 Page: 444-453
Author(s): Swatishree Sradhanjali,Mamatha M. Reddy
Resveratrol in Cancer: Cellular and Mitochondrial Consequences of Proton Transport Inhibition
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 1 Year: 2012 Page: 1338-1344
Author(s): Guillermo Lopez-Lluch, Sara Santa Cruz-Calvo, Placido Navas
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 151-162
Author(s): Sylvia S. Gayle, Samuel L.M. Arnold, Ruth M. ORegan, Rita Nahta